Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2576 Target Snapshot

Dihydrofolate reductase · SINGLE PROTEIN · Saccharomyces cerevisiae S288c

67Compounds
2Assays
2Approved Drugs
49.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P07807. Use UniProt P07807 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P07807 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dihydrofolate reductase as ChEMBL target CHEMBL2576, mapped to UniProt P07807. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dihydrofolate reductase
SINGLE PROTEIN · Saccharomyces cerevisiae S288c
As of 2026-09-14
ChEMBL target ID
CHEMBL2576
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P07807
Dihydrofolate reductase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dihydrofolate reductase is the right protein anchor across sources, using UniProt P07807 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDihydrofolate reductase
UniProt AccessionP07807
Component TypeProtein
Sequence Length211 aa

Dihydrofolate reductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dihydrofolate reductase, mapped to UniProt P07807. Sequence length is 211 aa.

Mapped IDP07807
Review nameDihydrofolate reductase
OrganismSaccharomyces cerevisiae S288c
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5049.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL7492 7.51 IC50 31.0 Clinical
CHEMBL300603 7.42 IC50 38.0 Preclinical
CHEMBL54538 7.4 IC50 40.0 Preclinical
CHEMBL119 7.38 IC50 42.0 Approved
CHEMBL55727 7.28 IC50 52.0 Preclinical
CHEMBL57624 7.04 IC50 91.0 Preclinical
CHEMBL54792 7.01 IC50 97.0 Preclinical
CHEMBL52930 6.92 IC50 120.0 Preclinical
CHEMBL53872 6.92 IC50 120.0 Preclinical
CHEMBL52688 6.89 IC50 130.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
10
5.5
13
6.0
15
6.5
6
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TRIMETREXATE
CHEMBL119
Approved 1993
Assay Landscape

Assay Landscape

2
Total Assays
49
Tested Compounds
1
Assay Types
Binding — 2 assays, 49 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0
single protein format 1 49 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine